499 filings
Page 4 of 25
8-K/A
tlvr0kldj0
30 Jul 21
Financial Statements and Exhibits
11:09am
8-K
xdrj9q5yw
28 Jul 21
Cytocom Inc. Announces Completed Merger with Cleveland BioLabs
8:30am
8-K
s739 f6dqg2edj0l
6 Jul 21
Departure of Directors or Certain Officers
5:01pm
425
txj1f1
17 Jun 21
Business combination disclosure
5:16pm
EFFECT
bbx497bwxuri1g
11 Jun 21
Notice of effectiveness
12:15am
424B3
ss8swk7wjsyl78nl
10 Jun 21
Prospectus supplement
5:02pm
CORRESP
p8wwrq vggj1si1
8 Jun 21
Correspondence with SEC
12:00am
CORRESP
c7jnwf3 z12huq15i3
4 Jun 21
Correspondence with SEC
12:00am
UPLOAD
4266emq bhl
24 May 21
Letter from SEC
12:00am
S-4/A
n2d0u9fdw
7 May 21
Registration of securities issued in business combination transactions (amended)
5:10pm
CORRESP
w3apv av2
7 May 21
Correspondence with SEC
12:00am
UPLOAD
nyoxbd4fk0 vytjp2cuk
25 Feb 21
Letter from SEC
12:00am
8-K
z9xdf0et2f
23 Feb 21
Cleveland BioLabs, Inc. Announces $14 Million Registered Direct Offering of Common Stock
5:30pm
424B5
928nq3
22 Feb 21
Prospectus supplement for primary offering
5:21pm
8-K
4dh4f u2uw4ky
19 Feb 21
Results of Operations and Financial Condition
8:52am
8-K
40112czw0ro bmbeambf
17 Feb 21
Other Events
4:18pm
425
3t9vr
17 Feb 21
Business combination disclosure
4:16pm